Cytokinetics (CYTK) Misses Q3 EPS by 59c

Cytokinetics (NASDAQ: CYTK) reported Q3 EPS of ($1.35), $0.59 worse than the analyst estimate of ($0.76).

For earnings history and earnings-related data on Cytokinetics (CYTK) click here.

You May Also Be Interested In

• Is Treasury selloff a major issue for stock market bulls?
• Seritage Growth Properties (SRG) Reports Q2 Loss of $0.13
• Motorsport Games Inc. (MSGM) Tops Q2 EPS by 33c